Melanoma

Melanoma is a form of cancer that begins in melanocytes (cells that make the pigment melanin). It may begin in a mole (skin melanoma), but can also begin in other pigmented tissues, such as in the eye or in the intestines.
What are Melanomas?

The treatment of melanoma may involve surgery, immunotherapy, targeted therapy, chemotherapy or radiotherapy, or a combination of several treatment techniques. Each of these treatments is outlined below.

Read More

Overview

Feature Articles

Latest Melanoma News and Research

New peptide molecule offers hope for emphysema

New peptide molecule offers hope for emphysema

ALKBH5 enzyme shows promising target for cancer immunotherapy

ALKBH5 enzyme shows promising target for cancer immunotherapy

A blood test may be an easy way to predict who will benefit from immunotherapy

A blood test may be an easy way to predict who will benefit from immunotherapy

Avoiding care during the pandemic could mean life or death

Avoiding care during the pandemic could mean life or death

Immunosuppressive steroids help tumors to evade the immune system

Immunosuppressive steroids help tumors to evade the immune system

Study identifies potential drug targets for developing new cancer immunotherapies

Study identifies potential drug targets for developing new cancer immunotherapies

Researchers identify targeted treatment strategy for malignant pleural mesothelioma

Researchers identify targeted treatment strategy for malignant pleural mesothelioma

Experts caution against routine use of current GEP tests for melanoma patients

Experts caution against routine use of current GEP tests for melanoma patients

Cancer-related care has decreased since the start of COVID-19

Cancer-related care has decreased since the start of COVID-19

Combining two immunotherapies into a single treatment found to be more effective

Combining two immunotherapies into a single treatment found to be more effective

JRC releases 2020 estimates on cancer burden in the EU

JRC releases 2020 estimates on cancer burden in the EU

Research could lead to more efficient cellular immunotherapies for advanced cancers

Research could lead to more efficient cellular immunotherapies for advanced cancers

National Cancer Institute renews designation of HCI as Comprehensive Cancer Center

National Cancer Institute renews designation of HCI as Comprehensive Cancer Center

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Groundbreaking technology could enhance therapeutic efficiency of nanomedicines

Pembrolizumab can improve outcomes in patients with metastatic melanoma

Pembrolizumab can improve outcomes in patients with metastatic melanoma

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Stand Up To Cancer announces new effort to achieve health equity for underserved lung cancer patients

Biological anti-tumor mechanism can provide long-term immune response against tumors

Biological anti-tumor mechanism can provide long-term immune response against tumors

Study shows safety and effectiveness of PET radiotracer in imaging glioblastomas

Study shows safety and effectiveness of PET radiotracer in imaging glioblastomas

Immunicom and Sheba Medical Center initiate clinical trial to evaluate novel cancer treatment

Immunicom and Sheba Medical Center initiate clinical trial to evaluate novel cancer treatment

PRMT5 inhibitors can help treat advanced melanoma

PRMT5 inhibitors can help treat advanced melanoma